By a News Reporter-Staff News Editor at -- According to news reporting originating from Washington, D.C. , by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Dusa Pharmaceuticals Inc. (Form CT ORDER) was posted on ... Equities.com, 1 month ago
Taro Pharmaceutical Industries' (TARO) CEO Kal Sundaram on Q4 2016 Results - Earnings Call Transcript
Taro Pharmaceutical Industries Ltd (NYSE: TARO ) Q4 2016 Results Earnings Conference Call May 27, 2016, 08:30 AM ET Executives William Coote - VP and Treasurer Dilip Shanghvi - Chairman Kal Sundaram - CEO Mike Kalb - CFO ...Seeking Alpha, 3 days ago
By Sanam Mirchandani MUMBAI: Credit Suisse has upgraded shares of Sun Pharmaceutical Industries to 'outperform' from 'neutral' and raised target price to Rs 925 from Rs 775 stating that checks suggest the company has taken a price increase in all ...Economic Times, 3 weeks ago
MUMBAI: Sun Pharmaceutical Industries received US Food and Drug Administration approval for BromSite, used to relieve post-operative inflammation and prevention of eye pain in patients undergoing cataract surgery, a significant boost to the ...Economic Times, 1 month ago
GLOBAL SKIN DISEASE TREATMENT MARKET REPORT 2016 - ANALYSIS, TECHNOLOGIES & FORECASTS - KEY VENDORS : Abbvie, Eli Lilly, Genetech - Research and Markets
Research and Markets ( http://www.researchandmarkets.com/research/r8mk9w/skin_disease ) has announced the addition of the "Skin Disease Treatment Technologies and Global Markets" report to their offering. This report provides detailed market, ...4 Traders, 2 months ago
on your WebpageAdd Widget >Get your members hooked!